Gender differences in seasonal variation of urine stone risk factorsPARKS, Joan H; BARSKY, Robert; COE, Fredric L et al.The Journal of urology. 2003, Vol 170, Num 2, pp 384-388, issn 0022-5347, 5 p., 1Article

Thiazide does not affect urine oxalate excretionPARKS, Joan H; COE, Fredric L.The Journal of urology. 2003, Vol 170, Num 2, pp 393-396, issn 0022-5347, 4 p., 1Article

Evidence for durable kidney stone prevention over several decadesPARKS, Joan H; COE, Fredric L.BJU international (Papier). 2009, Vol 103, Num 9, pp 1238-1246, issn 1464-4096, 9 p.Article

Changes in urine volume accomplished by physicians treating nephrolithiasisPARKS, Joan H; GOLDFISCHER, Evan R; COE, Fredric L et al.The Journal of urology. 2003, Vol 169, Num 3, pp 863-866, issn 0022-5347, 4 p.Article

Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuriaFAVUS, Murray J; KARNAUSKAS, Alexander J; PARKS, Joan H et al.The Journal of clinical endocrinology and metabolism. 2004, Vol 89, Num 10, pp 4937-4943, issn 0021-972X, 7 p.Article

Clinical use of cystine supersaturation measurementsNAKAGAWA, Y; ASPLIN, John R; GOLDFARB, David S et al.The Journal of urology. 2000, Vol 164, Num 5, pp 1481-1485, issn 0022-5347Article

Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasisASPLIN, John R; BAUER, Kimberly A; KINDER, Jennifer et al.Kidney international. 2003, Vol 63, Num 2, pp 662-669, issn 0085-2538, 8 p.Article

Causes and consequences of kidney loss in patients with nephrolithiasisWORCESTER, Elaine; PARKS, Joan H; JOSEPHSON, Michelle A et al.Kidney international. 2003, Vol 64, Num 6, pp 2204-2213, issn 0085-2538, 10 p.Article

Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patientsWORCESTER, Elaine M; COE, Fredric L; EVAN, Andrew P et al.American journal of physiology. Renal physiology. 2008, Vol 64, Num 5, issn 1931-857X, F1286-F1294Article

Proportional reduction of urine supersaturation during nephrolithiasis treatmentCOE, Fredric L; WISE, Henry; PARKS, Joan H et al.The Journal of urology. 2001, Vol 166, Num 4, pp 1247-1251, issn 0022-5347Conference Paper

Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practiceMARDIS, Hal K; PARKS, Joan H; MULLER, Georg et al.The Journal of urology. 2004, Vol 171, Num 1, pp 85-88, issn 0022-5347, 4 p.Article

Urine calcium and volume predict coverage of renal papilla by Randall's plaqueKUO, Ramsay L; LINGEMAN, James E; EVAN, Andrew P et al.Kidney international. 2003, Vol 64, Num 6, pp 2150-2154, issn 0085-2538, 5 p.Article

A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasisPARKS, Joan H; GOLDFISHER, Evan; ASPLIN, John R et al.The Journal of urology. 2002, Vol 167, Num 4, pp 1607-1612, issn 0022-5347Article

Reduced crystallization inhibition by urine from women with nephrolithiasisASPLIN, John R; PARKS, Joan H; NAKAGAWA, Yashushi et al.Kidney international. 2002, Vol 61, Num 5, pp 1821-1829, issn 0085-2538Article

Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidismPARKS, Joan H; COE, Fredric L; EVAN, Andrew P et al.BJU international (Papier). 2009, Vol 103, Num 5, pp 670-678, issn 1464-4096, 9 p.Article

Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with timePARKS, Joan H; COE, Fredric L; EVAN, Andrew P et al.Nephrology, dialysis, transplantation (Print). 2009, Vol 24, Num 1, pp 130-136, issn 0931-0509, 7 p.Article

Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasisWORCESTER, Elaine M; COE, Fredric L; EVAN, Andrew P et al.BJU international (Papier). 2006, Vol 97, Num 6, pp 1285-1290, issn 1464-4096, 6 p.Article

Differences in urine volume and supersaturation in 2 physician networksCOE, Fredric L; WISE, Henry; PARKS, Joan H et al.The Journal of urology. 2001, Vol 166, Num 2, pp 423-428, issn 0022-5347Article

Patient adherence to long-term medical treatment of kidney stones. Commentary. Authors' replyPARKS, Joan H; ASPLIN, John R; COE, Fredric L et al.The Journal of urology. 2001, Vol 166, Num 6, pp 2057-2060, issn 0022-5347Article

Urine stone risk factors in nephrolithiasis patients with and without bowel diseasePARKS, Joan H; WORCESTER, Elaine M; O'CONNOR, R. Corey et al.Kidney international. 2003, Vol 63, Num 1, pp 255-265, issn 0085-2538, 11 p.Article

Solid phase assay of urine cystine supersaturation in the presence of cystine binding drugsCOE, Fredric L; CLARK, Cyndi; PARKS, Joan H et al.The Journal of urology. 2001, Vol 166, Num 2, pp 688-693, issn 0022-5347Article

Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasisWORCESTER, Elaine M; GILLEN, Daniel L; EVAN, Andrew P et al.American journal of physiology. Renal physiology. 2007, Vol 61, Num 1, issn 1931-857X, F66-F75Article

Renal function in patients with nephrolithiasis. CommentaryWORCESTER, Elaine M; PARKS, Joan H; EVAN, Andrew P et al.The Journal of urology. 2006, Vol 176, Num 2, pp 600-603, issn 0022-5347, 4 p.Article

Stone formation is proportional to papillary surface coverage by Randall's plaque. CommentaryKIM, Samuel C; COE, Fredric L; TINMOUTH, William W et al.The Journal of urology. 2005, Vol 173, Num 1, pp 117-119, issn 0022-5347, 3 p.Article

Association of urinary pH with body weight in nephrolithiasisMAALOUF, Naim M; SAKHAEE, Khashayar; PARKS, Joan H et al.Kidney international. 2004, Vol 65, Num 4, pp 1422-1425, issn 0085-2538, 4 p.Article